Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Sharing lessons learnt across European cardiovascular research consortia.

de Jong L, Bobeldijk-Pastorova I, Erdmann J, Bijker-Schreurs M, Schunkert H, Kuivenhoven JA, van Gool AJ.

Drug Discov Today. 2020 Jan 22. pii: S1359-6446(20)30035-0. doi: 10.1016/j.drudis.2020.01.009. [Epub ahead of print] Review.

PMID:
31981480
2.

Management of HBV Infection and Prevention of HBV Reactivation in Children with Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic or Biological Modifier Therapies.

Indolfi G, Abdel-Hady M, Bansal S, Debray D, Smets F, Czubkowski P, van der Woerd W, Samyn M, Jahnel J, Gupte G, Zellos A, Mozer-Glassberg Y, Verkade HJ, Sokal E, Fischler B.

J Pediatr Gastroenterol Nutr. 2020 Jan 21. doi: 10.1097/MPG.0000000000002628. [Epub ahead of print]

PMID:
31977956
3.

The effects of bariatric surgery on clinical profile, DNA methylation, and ageing in severely obese patients.

Fraszczyk E, Luijten M, Spijkerman AMW, Snieder H, Wackers PFK, Bloks VW, Nicoletti CF, Nonino CB, Crujeiras AB, Buurman WA, Greve JW, Rensen SS, Wolffenbuttel BHR, van Vliet-Ostaptchouk JV.

Clin Epigenetics. 2020 Jan 20;12(1):14. doi: 10.1186/s13148-019-0790-2.

4.

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.

Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers DMAE, Masclee AAM, Fu J, Kurilshikov A, Wijmenga C, Zhernakova A, Weersma RK.

Nat Commun. 2020 Jan 17;11(1):362. doi: 10.1038/s41467-019-14177-z.

5.

Patients suffering from psychological impairments following critical illness are in need of information.

Vlake JH, van Genderen ME, Schut A, Verkade M, Wils EJ, Gommers D, van Bommel J.

J Intensive Care. 2020 Jan 9;8:6. doi: 10.1186/s40560-019-0422-0. eCollection 2020.

6.

Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas.

Liu J, Lahousse L, Nivard MG, Bot M, Chen L, van Klinken JB, Thesing CS, Beekman M, van den Akker EB, Slieker RC, Waterham E, van der Kallen CJH, de Boer I, Li-Gao R, Vojinovic D, Amin N, Radjabzadeh D, Kraaij R, Alferink LJM, Murad SD, Uitterlinden AG, Willemsen G, Pool R, Milaneschi Y, van Heemst D, Suchiman HED, Rutters F, Elders PJM, Beulens JWJ, van der Heijden AAWA, van Greevenbroek MMJ, Arts ICW, Onderwater GLJ, van den Maagdenberg AMJM, Mook-Kanamori DO, Hankemeier T, Terwindt GM, Stehouwer CDA, Geleijnse JM, 't Hart LM, Slagboom PE, van Dijk KW, Zhernakova A, Fu J, Penninx BWJH, Boomsma DI, Demirkan A, Stricker BHC, van Duijn CM.

Nat Med. 2020 Jan;26(1):110-117. doi: 10.1038/s41591-019-0722-x. Epub 2020 Jan 13.

PMID:
31932804
7.

The association between dietary patterns before and in early pregnancy and the risk of gestational diabetes mellitus (GDM): Data from the Malaysian SECOST cohort.

Yong HY, Mohd Shariff Z, Mohd Yusof BN, Rejali Z, Appannah G, Bindels J, Tee YYS, van der Beek EM.

PLoS One. 2020 Jan 10;15(1):e0227246. doi: 10.1371/journal.pone.0227246. eCollection 2020.

8.

Trimethylamine-N-oxide is present in human follicular fluid and is a negative predictor of embryo quality.

Nagy RA, Homminga I, Jia C, Liu F, Anderson JLC, Hoek A, Tietge UJF.

Hum Reprod. 2020 Jan 9. pii: dez224. doi: 10.1093/humrep/dez224. [Epub ahead of print]

PMID:
31916569
9.

Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.

Verzijl CRC, Van De Peppel IP, Struik D, Jonker JW.

Expert Opin Investig Drugs. 2020 Jan 3:1-9. doi: 10.1080/13543784.2020.1708898. [Epub ahead of print]

PMID:
31899984
10.

A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial.

Kouwenhoven SMP, Antl N, Finken MJJ, Twisk JWR, van der Beek EM, Abrahamse-Berkeveld M, van de Heijning BJM, Schierbeek H, Holdt LM, van Goudoever JB, Koletzko BV.

Am J Clin Nutr. 2019 Dec 23. pii: nqz308. doi: 10.1093/ajcn/nqz308. [Epub ahead of print]

PMID:
31868201
11.

Podocytes maintain high basal levels of autophagy independent of mtor signaling.

Bork T, Liang W, Yamahara K, Lee P, Tian Z, Liu S, Schell C, Thedieck K, Hartleben B, Patel K, Tharaux PL, Lenoir O, Huber TB.

Autophagy. 2019 Dec 23:1-17. doi: 10.1080/15548627.2019.1705007. [Epub ahead of print]

PMID:
31865844
12.

Farnesoid X receptor and bile acids regulate vitamin A storage.

Saeed A, Yang J, Heegsma J, Groen AK, van Mil SWC, Paulusma CC, Zhou L, Wang B, Faber KN.

Sci Rep. 2019 Dec 20;9(1):19493. doi: 10.1038/s41598-019-55988-w.

13.

Relationship between gut microbiota and circulating metabolites in population-based cohorts.

Vojinovic D, Radjabzadeh D, Kurilshikov A, Amin N, Wijmenga C, Franke L, Ikram MA, Uitterlinden AG, Zhernakova A, Fu J, Kraaij R, van Duijn CM.

Nat Commun. 2019 Dec 20;10(1):5813. doi: 10.1038/s41467-019-13721-1.

14.

Long-Term Neurodevelopmental Outcomes in Children with Biliary Atresia.

Rodijk LH, den Heijer AE, Hulscher JBF, Alizadeh BZ, de Kleine RHJ, Verkade HJ, Bruggink JLM.

J Pediatr. 2019 Dec 9. pii: S0022-3476(19)31465-9. doi: 10.1016/j.jpeds.2019.10.054. [Epub ahead of print]

PMID:
31831162
15.

Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling.

Piek A, Koonen DPY, Schouten EM, Lindtstedt EL, Michaëlsson E, de Boer RA, Silljé HHW.

Sci Rep. 2019 Dec 10;9(1):18765. doi: 10.1038/s41598-019-55263-y.

16.

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Saeed A, Hoogerland JA, Wessel H, Heegsma J, Derks TGJ, Veer E, Mithieux G, Rajas F, Oosterveer MH, Faber KN.

Hum Mol Genet. 2019 Dec 9. pii: ddz283. doi: 10.1093/hmg/ddz283. [Epub ahead of print]

PMID:
31813960
17.

Cohort Profile: The Dutch Perined-Lifelines birth cohort.

Salavati N, Bakker MK, van der Beek EM, Erwich JHM.

PLoS One. 2019 Dec 5;14(12):e0225973. doi: 10.1371/journal.pone.0225973. eCollection 2019.

18.

Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations.

van den Boogert MAW, Crunelle CL, Ali L, Larsen LE, Kuil SD, Levels JHM, Schimmel AWM, Konstantopoulou V, Guerin M, Kuivenhoven JA, Dallinga-Thie GM, Stroes ESG, Lefeber DJ, Holleboom AG.

J Inherit Metab Dis. 2019 Dec 4. doi: 10.1002/jimd.12200. [Epub ahead of print]

PMID:
31800099
19.

High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.

Josefs T, Wouters K, Tietge UJF, Annema W, Dullaart RPF, Vaisar T, Arts ICW, van der Kallen CJH, Stehouwer CDA, Schalkwijk CG, Goldberg IJ, Fisher EA, van Greevenbroek MMJ.

J Clin Lipidol. 2019 Oct 31. pii: S1933-2874(19)30319-8. doi: 10.1016/j.jacl.2019.10.012. [Epub ahead of print]

PMID:
31791716
20.

GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis.

Yu H, Rimbert A, Palmer AE, Toyohara T, Xia Y, Xia F, Ferreira LMR, Chen Z, Chen T, Loaiza N, Horwitz NB, Kacergis MC, Zhao L; BIOS Consortium, Soukas AA, Kuivenhoven JA, Kathiresan S, Cowan CA.

Cell. 2019 Nov 27;179(6):1276-1288.e14. doi: 10.1016/j.cell.2019.10.034.

PMID:
31778654

Supplemental Content

Loading ...
Support Center